Globally, neurological disorders are the main cause of death. It is defined as both central and peripheral nervous system disorders. The diseases primarily affect the elderly population. It may progress and necessitate long-term treatment. Congenital neurological abnormalities appear during the early stages of embryo development and can be detected at birth. A variety of factors, such as traumatic brain injuries, immunological problems, postnatal injections, spinal cord injuries, neoplasia, and exposure to ambient chemicals or poisons, can cause acquired neurological disorders after birth. Many bacterial, viral, fungal, and parasite diseases can damage the nervous system, resulting in neurological illnesses.
Frequently Asked Questions
The market is segmented based on Segmentation, By Indication (Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Neurological Disorder Drugs Market size was valued at USD 94.30 USD Billion in 2024.
The Global Neurological Disorder Drugs Market is projected to grow at a CAGR of 5.9% during the forecast period of 2025 to 2032.
The major players operating in the market include Merck KGaA , Eisai Co.Ltd. , AstraZeneca , Sanofi , Novartis AG , Abbott , F. Hoffmann-La Roche Ltd. , Teva Pharmaceutical Industries Ltd. , Pfizer Inc. , GlaxoSmithKline plc , WOCKHARDT , Novo Nordisk A/S , Glenmark Pharmaceuticals Limited , Cipla Inc. , Bausch Health Companies Inc. , Otsuka America PharmaceuticalInc. , Johnson &, Johnson Private Limited , Takeda Pharmaceutical Company Limited , Sumitomo Corporation , Biocon .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
